-
10007518-1A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 µM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1
-
10007518-10A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 µM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1
-
10007518-5A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 µM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1
-
10007518-50A competitive antagonist of TRPV1 which blocks the capsaicin-induced uptake of Ca2+ in neonatal rat dorsal root ganglia (IC50 = 0.42 µM) and Chinese hamster ovary cells (IC50 = 17 nM) does not block acid- or heat-induced activation of TRPV1
-
18172-1A coniferyl ester that acts as a partial agonist of TRPV1 (EC<sub>50</sub> = 3.2 µM), eliciting only 20% of the maximum response induced by capsaicin.
-
18172-10A coniferyl ester that acts as a partial agonist of TRPV1 (EC<sub>50</sub> = 3.2 µM), eliciting only 20% of the maximum response induced by capsaicin.
-
18172-25A coniferyl ester that acts as a partial agonist of TRPV1 (EC<sub>50</sub> = 3.2 µM), eliciting only 20% of the maximum response induced by capsaicin.
-
18172-5A coniferyl ester that acts as a partial agonist of TRPV1 (EC<sub>50</sub> = 3.2 µM), eliciting only 20% of the maximum response induced by capsaicin.
-
15313-1An ACE inhibitor (IC<sub>50</sub> = 6.3 nM) that does not exhibit a domain preference for binding either the C- or N-terminal active sites of the somatic form of ACE reversibly inhibits LTA4 hydrolase, inhibiting LTB4 synthesis (IC<sub>50</sub> =
-
15313-10An ACE inhibitor (IC<sub>50</sub> = 6.3 nM) that does not exhibit a domain preference for binding either the C- or N-terminal active sites of the somatic form of ACE reversibly inhibits LTA4 hydrolase, inhibiting LTB4 synthesis (IC<sub>50</sub> =
-
15313-25An ACE inhibitor (IC<sub>50</sub> = 6.3 nM) that does not exhibit a domain preference for binding either the C- or N-terminal active sites of the somatic form of ACE reversibly inhibits LTA4 hydrolase, inhibiting LTB4 synthesis (IC<sub>50</sub> =
-
15313-5An ACE inhibitor (IC<sub>50</sub> = 6.3 nM) that does not exhibit a domain preference for binding either the C- or N-terminal active sites of the somatic form of ACE reversibly inhibits LTA4 hydrolase, inhibiting LTB4 synthesis (IC<sub>50</sub> =